상세 보기
A multicenter phase II study of etoposide, methylprednisolone,high-dose cytarabine and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma: CISL study
- 제목
- A multicenter phase II study of etoposide, methylprednisolone,high-dose cytarabine and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma: CISL study
- 저자
- 원영웅
- 발행일
- 2016-05-27
- 학회명
- 제57차 대한혈액학회 춘계학술대회
- 개최지
- 대한민국 서울